Home » Genzyme Blood Cancer Treatment Shows Promise
Genzyme Blood Cancer Treatment Shows Promise
Genzyme Corp., a Cambridge biotechnology company, said it is encouraged by early test results
of its drug Mozobil as part of a potential strategy to attack blood cancers.
The Boston Globe
The Boston Globe
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May